Lowered expression of galectin-2 is associated with lymph node metastasis in gastric cancer. 2012

Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
BRI, Korea Institute of Science and Technology, 39-1 Hawolgok, Seongbuk, Seoul 136-791, Korea.

BACKGROUND Lymph node metastasis (LNM) is recognized as an important factor in the progression of tumor malignancy. It is required to discover molecular markers for the prediction of LNM in gastric cancers (GCs). METHODS An isotope coded affinity tag (ICAT) method and mass spectrometry were used for the quantitative profiling of LNM-related proteins. Western blot analysis of the identified proteins and immunohistochemistry on a tissue microarray comprising 120 GC cases were performed for validation. RESULTS We identified 151 differentially expressed proteins (DEPs) with an abundance ratio greater than 1.5-fold. The proteins upregulated in LNM-negative GCs were largely populated with proteins related to cell death. Among the DEPs, galectin-2 was further tested because its expression level was significantly higher in LNM-negative GCs (~12-fold, p < 0.0001) and its expression is known to be not ubiquitous but confined to the gastrointestinal tract. Immunohistochemical analysis revealed that low expression of galectin-2 was significantly associated with LNM (p = 0.031) and advanced clinical stage (p = 0.024). The association of low galectin-2 with LNM was found even in early GCs (p = 0.020). CONCLUSIONS Our results show that proteomic analysis coupled with immunohistochemistry using tissue microarray is a useful tool for identifying LNM-associated proteins in GC. Also, loss of galectin-2 might play an important role in the aggressiveness of GC.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm

Related Publications

Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
October 2013, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
December 2001, Histopathology,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
September 2007, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
December 1994, Pathology international,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
June 2004, Biochemical and biophysical research communications,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
March 2018, Oncology letters,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
July 2018, Middle East journal of digestive diseases,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
May 2002, Cancer research,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
January 2017, PloS one,
Ji-Han Jung, and Hye-Jung Kim, and Jeonghun Yeom, and Changyoung Yoo, and Jihye Shin, and Jinyoung Yoo, and Chang Suk Kang, and Cheolju Lee
October 2013, Journal of experimental & clinical cancer research : CR,
Copied contents to your clipboard!